Similar Risk of Kidney Failure among Patients with Blinding Diseases Who Receive Ranibizumab, Aflibercept, and Bevacizumab: An Observational Health Data Sciences and Informatics Network Study
接受雷珠单抗、阿柏西普和贝伐珠单抗治疗的致盲性疾病患者发生肾衰竭的风险相似：一项观察性健康数据科学与信息学网络研究
期刊:Ophthalmology Retina
影响因子:5.7
doi:10.1016/j.oret.2024.03.014
Cai, Cindy X; Nishimura, Akihiko; Bowring, Mary G; Westlund, Erik; Tran, Diep; Ng, Jia H; Nagy, Paul; Cook, Michael; McLeggon, Jody-Ann; DuVall, Scott L; Matheny, Michael E; Golozar, Asieh; Ostropolets, Anna; Minty, Evan; Desai, Priya; Bu, Fan; Toy, Brian; Hribar, Michelle; Falconer, Thomas; Zhang, Linying; Lawrence-Archer, Laurence; Boland, Michael V; Goetz, Kerry; Hall, Nathan; Shoaibi, Azza; Reps, Jenna; Sena, Anthony G; Blacketer, Clair; Swerdel, Joel; Jhaveri, Kenar D; Lee, Edward; Gilbert, Zachary; Zeger, Scott L; Crews, Deidra C; Suchard, Marc A; Hripcsak, George; Ryan, Patrick B
